Guardant Health
GH
#1160
Rank
HK$157.29 B
Marketcap
HK$1,186
Share price
-1.60%
Change (1 day)
190.39%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2026 (TTM): -HK$26.48

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is -HK$26.58. In 2025 the company made an earnings per share (EPS) of -HK$25.96 an increase over its 2024 EPS that were of -HK$27.92.

EPS history for Guardant Health from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-HK$26.482.03%
2025-HK$25.96-7.02%
2024-HK$27.92-16.82%
2023-HK$33.56-33.12%
2022-HK$50.1960%
2021-HK$31.3755.04%
2020-HK$20.23207.14%
2019-HK$6.59-19.81%
2018-HK$8.21

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Neogen
NEOG
-HK$22.01-17.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
-HK$19.45-26.84%๐Ÿ‡บ๐Ÿ‡ธ USA